Location: Palo Alto, CA
CIK: 0001892134 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value: $1.381B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | HILLEVAX INC | 9,781,472 | $162M | 11.7% | $11.23 | — | COM | 43157M102 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 9,341,551 | $126M | 9.1% | $9.95 | +26.8% | ORDINARY SHARES | N62509109 |
| — | CHINOOK THERAPEUTICS INC | 4,345,559 | $101M | 7.3% | $17.28 | — | COM | 16961L106 |
| ARQT | Arcutis Biotherapeutics | 8,684,232 | $95.53M | 6.9% | $17.08 | -15.3% | COM | 03969K108 |
| MIRM | Mirum Pharmaceuticals, Inc. | 3,860,107 | $92.72M | 6.7% | $20.65 | +10.4% | COM | 604749101 |
| SNDX | Syndax Pharmaceuticals, Inc. | 3,708,838 | $78.33M | 5.7% | $17.68 | +40.7% | COM | 87164F105 |
| KRYS | KRYSTAL BIOTECH INC | 945,407 | $75.69M | 5.5% | $62.37 | +26.0% | COM | 501147102 |
| PHAT | Phathom Pharmaceuticals, Inc. | 8,407,152 | $60.03M | 4.3% | $14.12 | -37.8% | COM | 71722W107 |
| — | VERONA PHARMA PLC | 2,944,349 | $59.12M | 4.3% | $14.52 | — | SPONSORED ADS | 925050106 |
| PCVX | Vaxcyte, Inc. | 1,397,405 | $52.37M | 3.8% | $21.85 | +94.2% | COM | 92243G108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 2,164,739 | $38.62M | 2.8% | $19.41 | +29.4% | COM | 76243J105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 3,238,859 | $25.46M | 1.8% | $9.73 | -23.3% | COM | 483497103 |
| COGT | COGENT BIOSCIENCES INC | 2,159,154 | $23.3M | 1.7% | $7.19 | +78.0% | COM | 19240Q201 |
| — | ALPINE IMMUNE SCIENCES INC | 2,985,757 | $23.05M | 1.7% | $8.97 | — | COM | 02083G100 |
| TYRA | TYRA BIOSCIENCES INC | 1,421,310 | $22.84M | 1.7% | $11.75 | +1.3% | COM | 90240B106 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,414,823 | $22.72M | 1.6% | $20.24 | -8.6% | COM | 22663K107 |
| TARS | Tarsus Pharmaceuticals, Inc. | 1,787,527 | $22.47M | 1.6% | $17.82 | -17.9% | COM | 87650L103 |
| — | THESEUS PHARMACEUTICALS INC | 2,248,194 | $19.96M | 1.4% | $6.45 | — | COM | 88369M101 |
| ANAB | ANAPTYSBIO INC | 899,700 | $19.58M | 1.4% | $30.26 | -19.7% | COM | 032724106 |
| BBIO | BRIDGEBIO PHARMA INC | 1,171,650 | $19.43M | 1.4% | $11.66 | 0.0% | COM | 10806X102 |
| RVMD | REVOLUTION MEDICINES INC | 854,484 | $18.51M | 1.3% | $24.62 | 0.0% | COM | 76155X100 |
| ELVN | ENLIVEN THERAPEUTICS INC | 830,983 | $18.2M | 1.3% | $20.34 | 0.0% | COM | 29337E102 |
| ACAD | ACADIA PHARMACEUTICALS INC | 857,338 | $16.14M | 1.2% | $16.19 | +17.6% | COM | 004225108 |
| — | GRITSTONE BIO INC | 5,162,348 | $14.35M | 1.0% | $4.12 | — | COM | 39868T105 |
| — | MERUS N V | 746,479 | $13.74M | 1.0% | $25.59 | — | COM | N5749R100 |
| TRVI | TREVI THERAPEUTICS INC | 6,663,590 | $12.33M | 0.9% | $2.89 | -21.6% | COM | 89532M101 |
| MGNX | MACROGENICS INC | 1,703,204 | $12.21M | 0.9% | $6.02 | 0.0% | COM | 556099109 |
| REPL | REPLIMUNE GROUP INC | 686,762 | $12.13M | 0.9% | $18.89 | +25.9% | COM | 76029N106 |
| — | VECTIVBIO HLDG AG | 1,352,199 | $11.63M | 0.8% | $8.61 | — | ORD SHS | H9060V101 |
| — | CEREVEL THERAPEUTICS HLDNG I | 393,000 | $9.585M | 0.7% | $28.54 | — | COM | 15678U128 |
| IMVT | Immunovant, Inc. | 585,759 | $9.085M | 0.7% | $6.23 | +178.6% | COM | 45258J102 |
| — | SUTRO BIOPHARMA INC | 1,776,479 | $8.207M | 0.6% | $8.22 | — | COM | 869367102 |
| — | MORPHIC HLDG INC | 214,240 | $8.064M | 0.6% | $37.64 | — | COM | 61775R105 |
| ARVN | ARVINAS INC | 285,331 | $7.795M | 0.6% | $67.21 | -53.0% | COM | 04335A105 |
| RNAM | AVIDITY BIOSCIENCES INC | 500,000 | $7.675M | 0.6% | $14.91 | +47.6% | COM | 05370A108 |
| NTLA | INTELLIA THERAPEUTICS INC | 203,684 | $7.591M | 0.5% | $84.72 | -53.7% | COM | 45826J105 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 3,746,857 | $6.894M | 0.5% | $4.17 | — | SPON ADS | 05280R100 |
| — | AEROVATE THERAPEUTICS INC | 338,110 | $6.82M | 0.5% | $20.17 | — | COM | 008064107 |
| PRTA | PROTHENA CORP PLC | 127,900 | $6.199M | 0.4% | $58.56 | -9.8% | SHS | G72800108 |
| ZYME | ZYMEWORKS INC | 610,000 | $5.514M | 0.4% | $7.03 | +24.1% | COM | 98985Y108 |
| SLN | SILENCE THERAPEUTICS PLC | 881,173 | $5.463M | 0.4% | $19.00 | — | ADS | 82686Q101 |
| — | ALLAKOS INC | 1,112,684 | $4.951M | 0.4% | $6.12 | — | COM | 01671P100 |
| — | BLUEBIRD BIO INC | 1,440,757 | $4.582M | 0.3% | $6.33 | — | COM | 09609G100 |
| EWTX | EDGEWISE THERAPEUTICS INC | 682,461 | $4.552M | 0.3% | $9.27 | 0.0% | COM | 28036F105 |
| — | Passage Bio, Inc. | 3,756,915 | $3.598M | 0.3% | $3.10 | — | COM | 702712100 |
| ADCT | ADC THERAPEUTICS SA | 1,647,030 | $3.212M | 0.2% | $3.69 | 0.0% | SHS | H0036K147 |
| ACRS | ACLARIS THERAPEUTICS INC | 264,377 | $2.139M | 0.2% | $13.64 | -7.0% | COM | 00461U105 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 500,333 | $921K | 0.1% | $0.87 | — | *W EXP 11/22/202 | N62509117 |
| NBRVF | NABRIVA THERAPEUTICS PLC | 17,025 | $29,741 | 0.0% | $4.21 | -60.0% | SHS NEW 2022 | G63637139 |